Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Floyd Daniel Armstrong

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Pediatric Hematology/Oncology|March 18, 2014
In replyPatricia K Duffner, Floyd Daniel Armstrong, Kathleen Helton, et al.
Journal of Pediatric Hematology/Oncology|December 19, 2013
Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology GroupPatricia K Duffner, Floyd Daniel Armstrong, Lu Chen, et al.
The Lancet. Respiratory Medicine|June 8, 2024
Long-term outcomes of early exposure to repeated general anaesthesia in children with cystic fibrosis (CF-GAIN): a multicentre, open-label, randomised controlled phase 4 trialClaire Elizabeth Wainwright, Suzanna Vidmar, Vicki Anderson, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Pediatric Hematology/Oncology|March 18, 2014
In replyPatricia K Duffner, Floyd Daniel Armstrong, Kathleen Helton, et al.
Journal of Pediatric Hematology/Oncology|December 19, 2013
Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology GroupPatricia K Duffner, Floyd Daniel Armstrong, Lu Chen, et al.
The Lancet. Respiratory Medicine|June 8, 2024
Long-term outcomes of early exposure to repeated general anaesthesia in children with cystic fibrosis (CF-GAIN): a multicentre, open-label, randomised controlled phase 4 trialClaire Elizabeth Wainwright, Suzanna Vidmar, Vicki Anderson, et al.
Pageof 1